Dosage and administration
Warm solution to body temper- ature. The usual intravenous dose in cattle is 500 mL per 800 to 1,000 pounds of body weight.
Warm solution to body temper- ature. The usual intravenous dose in cattle is 500 mL per 800 to 1,000 pounds of body weight.
Store between 15 degrees C and 30 degrees C (59 degrees F and 86 degrees F).
Each 500 mL of sterile aqueous
solution contains:
Calcium ......................... 10.8 g
(as calcium borogluconate, equivalent
to calcium gluconate 23.2%)
Potassium ....................... 8.0 g
(as potassium chloride)
Phosphorus ..................... 2.5 g
(as sodium hypophosphite.H2O)
Magnesium ..................... 1.6 g
(as magnesium borogluconate)
Dextrose.H2O ................ 75.0 g
Milliequivalents per liter
Cations
Calcium .................. 1,080 mEq/L
Potassium ................. 410 mEq/L
Magnesium ............... 261 mEq/L
Sodium .................... 161 mEq/L
Anions
Borogluconate ......... 1,341 mEq/L
Chloride .................... 410 mEq/L
Hypophosphite ........... 161 mEq/L
For use as an aid in the treatment
of hypocalcemia (parturient paresis, milk fever),
hypomagnesemia (grass tetany), and other
conditions associated with calcium, magnesium,
phosphorus and potassium deficiencies in cattle.
Do not administer this
product to animals showing signs of cardiac
distress.
Administration should be made
slowly and with care to avoid adverse effects such
as heart block or shock. Perivascular or subcu-
taneous deposition of hypertonic solutions may
result in severe inflammation at the injection site.
This product contains no preservatives.
Use entire contents when first opened. Discard any
unused solution.
Warm solution to body temper-
ature. The usual intravenous dose
in cattle is 500 mL per 800 to
1,000 pounds of body weight.
Store between 15 degrees C and 30 degrees C (59 degrees F and 86 degrees F).
FOR ANIMAL USE ONLY
Federal law
restricts this drug to use
by or on the order of a
licensed veterinarian.
KEEP OUT OF REACH OF CHILDREN
TAKE TIME OBSERVE LABEL DIRECTIONS
18-805
RMS 92-543 Rev. 03-14
Lot No. Exp. Date
For Treatment of Milk Fever in Cattle
Net Contents: 500 mL
Manufactured for:
Clipper Distributing Company, LLC
St. Joseph, MO 64507
Trademarks are property of
Clipper Distributing Company, LLC
Manufactured by
Nova-Tech Inc.
Grand Island, NE 68801
| Class | Version | Type | Effective |
|---|---|---|---|
| CALCIUM CATION Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20230427 |
| MAGNESIUM CATION Pharmacologic Class Indexing | 4 | Indexing - Pharmacologic Class | 20180813 |
| POTASSIUM CATION Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0357319544078 | GTIN-13: 0357319544078 EAN-13: 0357319544078 GTIN-12: 357319544078 UPC-A: 357319544078 GTIN storage (14 digits): 00357319544078 | 92-543.jpg |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57319-544-07 | Cal-Phos 2 With Potassium | 500 mL in 1 BOTTLE, PLASTIC | INJECTION, SOLUTION | 500 | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 57319-544 | 57319-544-07 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Dextrose monohydrate | LX22YL083G | ACTIB |
| Potassium Chloride | 660YQ98I10 | ACTIM |
| Calcium Gluconate Monohydrate | CZN0MI5R31 | ACTIB |
| Phosphorus | 27YLU75U4W | ACTIB |
| Magnesium Gluconate | T42NAD2KHC | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dextrose | DEXTROSE MONOHYDRATE | Henry Schein, Inc. | 8cf6943f-16e8-4521-863c-09bb0b55e2a9 | 2026-09-09 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | REMEDYREPACK INC. | b8b77421-d687-45aa-82f6-d49bce644c10 | 2026-08-31 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 4ed365da-4e62-4329-c1b9-c197ab4fb6e1 | 2026-07-13 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 672264e3-9709-4bba-2a9d-12bf70c7396a | 2026-06-24 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| DEXTROSE | DEXTROSE MONOHYDRATE | Baxter Healthcare Corporation | 3bb406a9-f5cb-403a-b1bb-5c4facbea3d5 | 2026-06-11 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 10e98cb0-31a5-4ad1-3eaa-aa4af387a42d | 2026-06-02 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Henry Schein, Inc. | 40fd1ac4-39bb-45fb-ba99-4fb65481f231 | 2026-04-09 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Becton Dickinson and Company | 8e7046f8-841e-465a-af69-af9fb3d6799d | 2026-03-17 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | 3b8f2692-4371-4f1a-95af-b41842131fdd | 2026-03-13 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | BECTON DICKINSON AND COMPANY | 32132016-1870-481b-9816-e11beb03ca0b | 2026-01-08 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | bd250a46-d229-4e80-b5a1-b34169ccecc4 | 2025-12-17 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | ICU Medical, Inc. | 8b25b7e0-703e-4b43-a4eb-52863511602d | 2025-11-02 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | ICU Medical, Inc. | cb578dba-094c-4787-951d-763d12fd06e1 | 2025-11-01 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | ICU Medical Inc. | cdf35d11-fbc8-4f8e-85a8-33220312c0b4 | 2025-10-17 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | ProPharma Distribution | 3eff8bcd-6a33-428f-e063-6394a90afa68 | 2025-09-17 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Baxter Healthcare Company | bfc4224a-2fc9-4137-b4c6-9d2d6d948413 | 2025-07-30 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | ProPharma Distribution | 3842a9c0-8b15-1c94-e063-6394a90ae120 | 2025-07-18 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| DEXTROSE | DEXTROSE MONOHYDRATE | Baxter Healthcare Corporation | 36e9478c-5df0-4b47-b97d-de3626d7cb29 | 2025-06-30 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | FRESENIUS KABI USA, LLC | 576a22d8-5f2f-497e-80ad-1842ca74bb53 | 2024-08-22 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Becton Dickinson and Company | c1f72bce-4bef-49db-a8da-f26a703d6748 | 2024-08-15 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
Adverse event summaries are temporarily unavailable. Other product information remains available.